Zydus US Subsidiary Settles Antitrust Litigation for $5.9M

Key Transaction Details

Zydus Pharmaceuticals USA Inc. (ZPUI), a wholly owned subsidiary of Zydus Lifesciences Limited, entered into a Settlement Agreement with a putative class of Indirect Reseller Plaintiffs to resolve litigation matters. The litigation was proceeding as part of MDL No. 2724 (Case No. 16-md-2724), In re Generic Pharmaceuticals Pricing Antitrust Litigation, pending in the United States District Court for the Eastern District of Pennsylvania.

Settlement Terms

Pursuant to the Settlement, ZPUI has agreed to pay a total of USD 5.9 million to resolve the litigation matters. The Settlement contains a full and final release of all claims by the Indirect Reseller Plaintiffs and was entered into without any admission of fault or wrongdoing by ZPUI.